| Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data E Simons, M Ferrari, J Fricks, K Wannemuehler, A Anand, A Burton, ... The Lancet 379 (9832), 2173-2178, 2012 | 394 | 2012 |
| Knowledge of HIV status, sexual risk behaviors and contraceptive need among people living with HIV in Kenya and Malawi A Anand, RW Shiraishi, RE Bunnell, K Jacobs, N Solehdin, ... Aids 23 (12), 1565-1573, 2009 | 128 | 2009 |
| Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial A Anand, K Zaman, CF Estívariz, M Yunus, HE Gary, WC Weldon, TI Bari, ... Vaccine 33 (48), 6816-6822, 2015 | 112 | 2015 |
| Poliovirus vaccination options for achieving eradication and securing the endgame CF Estívariz, MA Pallansch, A Anand, SGF Wassilak, RW Sutter, ... Current opinion in virology 3 (3), 309-315, 2013 | 84 | 2013 |
| Increasing access to safe abortion services in rural India: experiences with medical abortion in a primary health center S Mundle, B Elul, A Anand, S Kalyanwala, S Ughade Contraception 76 (1), 66-70, 2007 | 66 | 2007 |
| Interference of monovalent, bivalent, and trivalent oral poliovirus vaccines on monovalent rotavirus vaccine immunogenicity in rural Bangladesh DM Emperador, DE Velasquez, CF Estivariz, B Lopman, B Jiang, ... Clinical Infectious Diseases 62 (2), 150-156, 2016 | 62 | 2016 |
| Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: a novel dose sparing immunization schedule A Anand, NA Molodecky, MA Pallansch, RW Sutter Vaccine 35 (22), 2993-2998, 2017 | 56 | 2017 |
| Unexpectedly high HIV prevalence among female sex workers in Bangkok, Thailand in a respondent-driven sampling survey C Manopaiboon, D Prybylski, W Subhachaturas, S Tanpradech, ... International journal of STD & AIDS 24 (1), 34-38, 2013 | 47 | 2013 |
| Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial CJ Snider, K Zaman, CF Estivariz, M Yunus, WC Weldon, ... The Lancet 393 (10191), 2624-2634, 2019 | 42 | 2019 |
| Bridging populations—sexual risk behaviors and hiv prevalence in clients and partners of female sex workers, Bangkok, Thailand 2007 NS Shah, RW Shiraishi, W Subhachaturas, A Anand, SJ Whitehead, ... Journal of Urban Health 88, 533-544, 2011 | 39 | 2011 |
| Fractional-dose inactivated poliovirus vaccine immunization campaign—Telangana State, India, June 2016 S Bahl MMWR. Morbidity and Mortality Weekly Report 65, 2016 | 38 | 2016 |
| Utility of antenatal HIV surveillance data to evaluate prevention of mother-to-child HIV transmission programs in resource-limited settings O Bolu, A Anand, A Swartzendruber, W Hladik, LH Marum, AA Sheikh, ... American journal of obstetrics and gynecology 197 (3), S17-S25, 2007 | 38 | 2007 |
| Impact of COVID-19 pandemic on global poliovirus surveillance DJ Zomahoun MMWR. Morbidity and mortality weekly report 69, 2021 | 35 | 2021 |
| Surveillance to track progress toward polio eradication—worldwide, 2016–2017 TJ Gardner MMWR. Morbidity and mortality weekly report 67, 2018 | 32 | 2018 |
| Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non … CF Estívariz, A Anand, HE Gary, M Rahman, J Islam, TI Bari, ... The Lancet Infectious Diseases 15 (8), 898-904, 2015 | 32 | 2015 |
| Vial usage, device dead space, vaccine wastage, and dose accuracy of intradermal delivery devices for inactivated poliovirus vaccine (IPV) C Jarrahian, A Rein-Weston, G Saxon, B Creelman, G Kachmarik, ... Vaccine 35 (14), 1789-1796, 2017 | 29 | 2017 |
| Cold-chain adaptability during introduction of inactivated polio vaccine in Bangladesh, 2015 MM Billah, K Zaman, CF Estivariz, CJ Snider, A Anand, LM Hampton, ... The Journal of infectious diseases 216 (suppl_1), S114-S121, 2017 | 25 | 2017 |
| Site factors may be more important than participant factors in explaining HIV test acceptance in the prevention of mother‐to‐child HIV transmission programme in Kenya, 2005 A Anand, RW Shiraishi, AA Sheikh, LH Marum, O Bolu, W Mutsotso, ... Tropical Medicine & International Health 14 (10), 1215-1219, 2009 | 25 | 2009 |
| Surveillance to track progress toward polio eradication—worldwide, 2019–2020 JN Tuma MMWR. Morbidity and Mortality Weekly Report 70, 2021 | 24 | 2021 |
| Developing rubella vaccination policy in Nepal—results from rubella surveillance and seroprevalence and congenital rubella syndrome studies SR Upreti, K Thapa, YV Pradhan, G Shakya, YD Sapkota, A Anand, ... The Journal of infectious diseases 204 (suppl_1), S433-S438, 2011 | 23 | 2011 |
